Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Novo Nordisk's FY2024 results confirmed the structural nature of the GLP-1 demand wave: total revenues grew 26% to DKK 290.4 billion (approximately USD 41 billion), with Obesity care revenues up 56% to DKK 65.1 billion (approximately USD 8.2 billion)
The study did not exclude any specific brand of drugs, but since Wegovy was only approved in Canada in November 2021, primarily for weight loss, it is likely the bulk of semaglutide users in the study were taking Ozempic, which is prescribed for diabetes
That we want
Glucagon activation promotes lipolysis, enhances hepatic fat utilization, and increases overall energy expenditure
This method may be more effective for certain health conditions
Its more of a gradual process, and understanding the typical timeline can really help manage your expectations
